Talarozole
Alternative Names: 115866; R115866Latest Information Update: 21 Feb 2022
Price :
$50 *
At a glance
- Originator Janssen L.P.
- Developer Stiefel Laboratories
- Class Azoles; Small molecules
- Mechanism of Action Aromatase inhibitors; Cytochrome P-450 enzyme system inhibitors; Retinoic acid metabolism modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Acne; Psoriasis
Most Recent Events
- 21 Feb 2022 Discontinued - Phase-II for Acne in Europe (PO) (Johnson & Johnson pipeline and GlaxoSmithKline pipeline, February 2022)
- 21 Feb 2022 Discontinued - Phase-II for Psoriasis in Europe (PO) (Johnson & Johnson pipeline and GlaxoSmithKline pipeline, February 2022)
- 22 Jul 2009 Stiefel Laboratories acquired by GlaxoSmithKline